De novo posttransplantation nonlymphoproliferative malignancies in liver transplant recipients

被引:7
作者
Boin, I. [1 ]
Leonardi, M. I. [1 ]
Stucchi, R. B. [1 ]
Ataide, E. C. [1 ]
Almeida, J. R. [1 ]
Barros, R. H. [1 ]
Leonardi, L. S. [1 ]
机构
[1] Univ Estadual Campinas, Unit Liver Transplantat, BR-13086030 Campinas, SP, Brazil
关键词
D O I
10.1016/j.transproceed.2007.07.084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The risk of developing de novo malignancies after liver transplantation is around 1% per year. The incidence varies from 3% to 15%; it is greater than that in the general population. The potential causes for cancer after solid organ grafting are: chronic immunosuppression and human herpes viral infection. The objective of this paper was to review the medical literature about the subject to verify the incidence of de novo malignancies in our service. We performed retrospective analysis of the medical files of 325 successive patients undergoing orthotopic liver transplantation from September 1991 to December 2006. We analyzed the type of tumor, the risk factors, the treatment modality, and the patient survivals. Recurrences of hepatocellular carcinoma were excluded. There were 5 (1.54%) men of average age 50.2 years, and an 80% mortality rate. Their survival time was affected by the nature of the tumor and by the late manifestations of intestinal obstruction allowing adequate surgical treatment. Four of the patients displayed heavy alcohol and tobacco consumption before transplantation. Screening for premalignant lesions must be strongly encouraged to achieve better postoperative results.
引用
收藏
页码:3284 / 3286
页数:3
相关论文
共 20 条
[1]   Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy [J].
Atassi, T ;
Thuluvath, PJ .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (01) :72-73
[2]  
De Kroon L, 2007, NETH J MED, V65, P252
[3]   Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis [J].
Duvoux, C ;
Delacroix, I ;
Richardet, JP ;
Roudot-Thoraval, F ;
Métreau, JM ;
Fagniez, PL ;
Dhumeaux, D ;
Cherqui, D .
TRANSPLANTATION, 1999, 67 (03) :418-421
[4]   Skin cancers after liver transplantation: What to do? [J].
Euvrard, S ;
Kanitakis, J .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :27-32
[5]   De novo malignancies after liver transplantation: A major cause of late death [J].
Fung, JJ ;
Jain, A ;
Kwak, EJ ;
Kusne, S ;
Dvorchik, I ;
Eghtesad, B .
LIVER TRANSPLANTATION, 2001, 7 (11) :S109-S118
[6]   Incidence and outcome of de novo malignancies after liver transplantation [J].
Galve, ML ;
Cuervas-Mons, V ;
Figueras, J ;
Herrero, I ;
Mata, M ;
Clemente, G ;
Prieto, M ;
Margarit, C ;
Bernardos, A ;
Casafont, F .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :1275-1277
[7]   Increased cancer risk after liver transplantation: a population-based study [J].
Haagsma, EB ;
Hagens, VE ;
Schaapveld, M ;
van den Berg, AP ;
de Vries, EGE ;
Klompmaker, IJ ;
Slooff, MJH ;
Jansen, PLM .
JOURNAL OF HEPATOLOGY, 2001, 34 (01) :84-91
[8]   DEVELOPMENT OF COLON CANCER AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH ULCERATIVE-COLITIS [J].
HIGASHI, H ;
YANAGA, K ;
MARSH, JW ;
TZAKIS, A ;
KAKIZOE, S ;
STARZL, TE .
HEPATOLOGY, 1990, 11 (03) :477-480
[9]   Posttransplant Lymphoproliferative disorders in liver transplantation - A 20-year experience [J].
Jain, A ;
Nalesnik, M ;
Reyes, J ;
Pokharna, R ;
Mazariegos, G ;
Green, M ;
Eghtesad, B ;
Marsh, W ;
Cacciarelli, T ;
Fontes, P ;
Abu-Elmagd, K ;
Sindhi, R ;
Demetris, J ;
Fung, J .
ANNALS OF SURGERY, 2002, 236 (04) :429-437
[10]   Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus [J].
Jain, A ;
DiMartini, A ;
Kashyap, R ;
Youk, A ;
Rohal, S ;
Fung, J .
TRANSPLANTATION, 2000, 70 (09) :1335-1342